OgilvyHealthworld UK has won a competitive pitch to develop and launch a new campaign for specialist medicines supplier Idis.
The campaign will promote Idis’ offerings to specialist patients who find normal drugs have no effect on their condition, and need unapproved but strictly controlled medicines.
Andrew Moody, marketing director at Idis, said “Ogilvy Healthworld have shown that they are really in tune with what we are trying to achieve.”
As a leading company in the industry Idis supply specialist drugs to over 60 countries worldwide from the 20,000 medicines in its database. They source about 20 new medicines a day and provide over 600 drugs through the “named patient” system every month.
Richard Marks, business unit head at Ogilvy Healthworld UK welcomed the forthcoming challenge.
“We look forward to working with Idis to increase understanding of the benefit of named patient programmes, and to help address the current market access issues facing the pharmaceutical sector” he said.
To read more about this story just click here
